Published in Int J Cardiol on October 10, 2005
Sociodemographic characteristics and diabetes predict invalid self-reported non-smoking in a population-based study of U.S. adults. BMC Public Health (2007) 0.91
Correlations of non-exercise activity thermogenesis to metabolic parameters in Japanese patients with type 2 diabetes. Diabetol Metab Syndr (2013) 0.83
Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J (2004) 7.84
Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial. Lancet (2008) 3.71
The second Euro Heart Survey on acute coronary syndromes: Characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J (2006) 3.62
A randomized trial of colchicine for acute pericarditis. N Engl J Med (2013) 3.60
Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial. Lancet (2004) 3.40
COlchicine for the Prevention of the Post-pericardiotomy Syndrome (COPPS): a multicentre, randomized, double-blind, placebo-controlled trial. Eur Heart J (2010) 3.02
Pretreatment with corticosteroids attenuates the efficacy of colchicine in preventing recurrent pericarditis: a multi-centre all-case analysis. Eur Heart J (2005) 2.47
Colchicine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy. Circulation (2011) 2.42
Bezafibrate for the secondary prevention of myocardial infarction in patients with metabolic syndrome. Arch Intern Med (2005) 2.22
Is immigration associated with an increase in risk factors and mortality among coronary artery disease patients? A cohort study of 13,742 patients. Isr Med Assoc J (2002) 2.13
Colchicine for the prevention of pericarditis: what we know and what we do not know in 2014 - systematic review and meta-analysis. J Cardiovasc Med (Hagerstown) (2014) 2.12
Functional class in patients with heart failure is associated with the development of diabetes. Am J Med (2003) 2.10
Efficacy of omega-3 fatty acid supplementation in primary and secondary prevention of coronary heart disease. Isr Med Assoc J (2004) 2.02
Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey. Eur Heart J (2006) 2.00
Long-term changes in serum cholesterol level does not influence the progression of coronary calcification. Int J Cardiol (2010) 1.99
Colchicine for recurrent pericarditis (CORP): a randomized trial. Ann Intern Med (2011) 1.86
Long-term prognostic significance of left atrial volume in acute myocardial infarction. J Am Coll Cardiol (2004) 1.76
Soluble intercellular adhesion molecule-1 and risk of future ischemic stroke: a nested case-control study from the Bezafibrate Infarction Prevention (BIP) study cohort. Stroke (2002) 1.70
Perceptual, social, and behavioral factors associated with delays in seeking medical care in patients with symptoms of acute stroke. Stroke (2006) 1.63
Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons. Cardiovasc Diabetol (2005) 1.61
Serum uric acid for risk stratification of patients with coronary artery disease. Cardiology (2009) 1.61
Coronary calcium by spiral computed tomography predicts cardiovascular events in high-risk hypertensive patients. J Hypertens (2004) 1.57
Effect of bundle branch block patterns on mortality in hospitalized patients with heart failure. Am J Cardiol (2008) 1.53
Prognosis of myopericarditis as determined from previously published reports. J Cardiovasc Med (Hagerstown) (2014) 1.52
Impact of the metabolic syndrome on the clinical outcomes of non-clinically diagnosed diabetic patients with acute coronary syndrome. Am J Cardiol (2007) 1.50
Relation of body mass index to mortality among men with coronary heart disease. Am J Cardiol (2010) 1.49
Management of pericardial effusion. Eur Heart J (2012) 1.48
Attenuation of progression of insulin resistance in patients with coronary artery disease by bezafibrate. Arch Intern Med (2006) 1.46
Calcification of the thoracic aorta as detected by spiral computed tomography among stable angina pectoris patients: association with cardiovascular events and death. Circulation (2008) 1.45
Should primary percutaneous coronary intervention be the preferred method of reperfusion therapy for patients with renal failure and ST-elevation acute myocardial infarction? Am J Cardiol (2006) 1.44
Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease. Circulation (2004) 1.42
Cardiac biomarkers and acute coronary syndromes--the Euro Heart Survey of Acute Coronary Syndromes Experience. Eur Heart J (2003) 1.42
"Masculinizing" effect on respiratory morbidity in girls from unlike-sex preterm twins: a possible transchorionic paracrine effect. Pediatrics (2007) 1.42
Primary angioplasty in patients following coronary artery bypass surgery: trends in application and outcome. Results from the acute coronary syndrome Israeli Survey (ACSIS) 2000-2008. Catheter Cardiovasc Interv (2011) 1.41
Excessively high bilirubin and exchange transfusion in very low birth weight infants. Acta Paediatr (2010) 1.40
Sex, age, and clinical presentation of acute coronary syndromes. Eur Heart J (2004) 1.40
Combination of the Killip and TIMI classifications for early risk stratification of patients with acute ST elevation myocardial infarction. Cardiology (2011) 1.40
2015 ESC Guidelines for the Diagnosis and Management of Pericardial Diseases. Rev Esp Cardiol (Engl Ed) (2015) 1.39
Cultural/ethnic differences in the prevalence of depressive symptoms among middle-aged women in Israel: the Women's Health at Midlife Study. Menopause (2012) 1.39
Major motives in non-acceptance of A/H1N1 flu vaccination: the weight of rational assessment. Vaccine (2010) 1.31
Outcome of early-onset sepsis in a national cohort of very low birth weight infants. Pediatrics (2010) 1.30
Risk of constrictive pericarditis after acute pericarditis. Circulation (2011) 1.28
Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction. Am J Cardiol (2006) 1.17
Controversial issues in the management of pericardial diseases. Circulation (2010) 1.17
Efficacy and safety of colchicine for pericarditis prevention. Systematic review and meta-analysis. Heart (2012) 1.16
The ubiquitous interleukin-6: a time for reappraisal. Cardiovasc Diabetol (2010) 1.16
Ischemic preconditioning: nearly two decades of research. A comprehensive review. Atherosclerosis (2004) 1.15
Is there an association between hypertension and cancer mortality? Am J Med (2002) 1.15
Effect of gender on outcomes of acute coronary syndromes. Am J Cardiol (2003) 1.13
Colchicine for the prevention of postpericardiotomy syndrome. Herz (2002) 1.13
Cognitive functions in severe congestive heart failure before and after an exercise training program. Int J Cardiol (2005) 1.12
Spiral computed tomography evidence of close correlation between coronary and thoracic aorta calcifications. Atherosclerosis (2004) 1.11
Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR). Cardiovasc Diabetol (2003) 1.10
Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction. Cardiovasc Diabetol (2012) 1.10
Effect of bezafibrate on incidence of type 2 diabetes mellitus in obese patients. Eur Heart J (2005) 1.09
Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level. Arterioscler Thromb Vasc Biol (2006) 1.09